Showing results (61-70 of 75) with videos related to
Sort By:
Pageof 8
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 5, 2001
Mycobacterium tuberculosis complex DNA from an extinct bison dated 17,000 years before the presentB M Rothschild, L D Martin, G Lev, et al.Experimental Cell Research|March 1, 1995
Mimosine differentially inhibits DNA replication and cell cycle progression in somatic cells compared to embryonic cells of Xenopus laevisY Wang, J Zhao, J Clapper, et al.British Journal of Anaesthesia|October 4, 2017
Isoflurane exposure for three hours triggers apoptotic cell death in neonatal macaque brainK K Noguchi, S A Johnson, G A Dissen, et al.Science (New York, N.Y.)|June 24, 2000
Nonavian feathers in a late Triassic archosaurT D Jones, J A Ruben, L D Martin, et al.Environmental Health Perspectives|December 24, 1997
The role of reactive oxygen and nitrogen species in the response of airway epithelium to particulatesL D Martin, T M Krunkosky, J A Dye, et al.Journal of Medicinal Chemistry|September 13, 1996
(E)-3-[6-[[(2,6-dichlorophenyl)thio]methyl]-3-(2-phenylethoxy)-2- pyridinyl]-2-propenoic acid: a high-affinity leukotriene B4 receptor antagonist with oral antiinflammatory activityR A Daines, P A Chambers, J J Foley, et al.Journal of Cardiovascular Pharmacology|November 15, 2000
Targeted disruption of the endothelin-B-receptor gene attenuates inflammatory nociception and cutaneous inflammation in miceD E Griswold, S A Douglas, L D Martin, et al.Journal of Medicinal Chemistry|September 30, 1994
(E)-3-[[[[6-(2-carboxyethenyl)-5-[[8-(4- methoxyphenyl)octyl]oxy]-2-pyridinyl]-methyl]thio]methyl]benzoic acid and related compounds: high affinity leukotriene B4 receptor antagonistsR A Daines, P A Chambers, D S Eggleston, et al.Molecular Pharmacology|September 25, 1999
Endothelin B receptor modulates inflammatory pain and cutaneous inflammationD E Griswold, S A Douglas, L D Martin, et al.The Journal of Biological Chemistry|May 30, 1998
Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migrationJ R White, J M Lee, P R Young, et al.Pageof 8